nach oben

International Journal of Mental Health and Addiction

Erschienen in:

14.12.2015

Dependence on Over the Counter (OTC) Codeine Containing Analgesics: Treatment and Recovery with Buprenorphine Naloxone

verfasst von: Marie Claire Van Hout, Ide Delargy, Gerry Ryan, Siobhan Flanagan, Hugh Gallagher

Erschienen in: International Journal of Mental Health and Addiction | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Misuse and dependence on prescribed and over the counter (OTC) codeine-combination analgesics is an emerging public health concern. We present a clinical case series of four adult patients dependent on OTC codeine combination analgesics in Ireland. Cases (two males/two females, aged 44–57 years) were consuming between 12 and 72 codeine-containing tablets/day. In three cases, consumption was linked to pain, with on-going misuse reflecting dependence on codeine. Cases were initiated on buprenorphine-naloxone (Suboxone®), stabilised on doses of between 4 mg/1 mg and 14 mg/3.5 mg per day and remain on treatment without additional opioid use, as verified by drug screening reports. Although anecdotal, these cases show the potential of effective opioid assisted treatment (OAT) using buprenorphine-naloxone (Suboxone®) to successfully treat this distinct form of opioid dependence disorder. Optimal service provision should recognise unique patient profiles and needs for this form of opioid dependence and incorporate psycho-social supports.

Amato, L., Davolia, M., Peruccia, C. A., Ferria, M., Faggiano, F., & Mattick, R. P. (2005). An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. Journal of Substance Abuse Treatment, 28(4), 321–329. doi:10.1016/j.jsat.2005.02.007.

Amato, L., Minozzi, S., Davoli, M., & Vecchi, S. (2011). Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database of Systematic Reviews, 10, CD004147. doi:10.1002/14651858.CD004147.pub4.PubMed

Bao, Y., Liu, Z., Epstein, D. H., Du, C., Shi, J., & Lu, L. (2009). A meta-analysis of retention in methadone maintenance by dose and dosing strategy. The American Journal of Drug and Alcohol Abuse, 35(1), 28–33. doi:10.1080/00952990802342899.CrossRefPubMedPubMedCentral

Connock M, Juarez Garcia A, Jowett S, Frew E, Liu Z, Taylor RJ, Fry-Smith A, Day E, Lintzeris N, Roberts T, Burls A, & Taylor RS. (2007). Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technology Assessment, 11(9):1–171, iii-iv. doi:10.3310/hta11090.

Conroy, S., & Hill, D. (2014). Failure to identify or effectively manage prescription opioid dependence acted as a gateway to heroin use—buprenorphine/naloxone treatment and recovery in a surgical patient. BMJ Case Reports. doi:10.1136/bcr-2014-207458.PubMed

Cooper, R. (2011). Respectable addiction - a qualitative study of over the counter medicine abuse in the UK. School of Health and Related Research (ScHARR): University of Sheffield.

Cooper, R. J. (2013). I can’t be an addict. I am.’ Over-the-counter medicine abuse: a qualitative study. British Medical Journal Open, 3(6). doi:10.1136/bmjopen-2013-002913.

Department of Health (England) and the devolved administrations. (2007). Drug misuse and dependence: UK Guidelines on Clinical Management. London. Department of Health (England), the Scottish Government, Welsh Assembly and Northern Ireland Executive.

Dole, V. P., & Nywsander, M. (1965). A medical treatment for diacetylmorphine (heroin) addiction. A clinical trial with methadone hydrochloride. The Journal of the American Medical Association, 193(8), 646–650. doi:10.1001/jama.1965.03090080008002.CrossRefPubMed

Doran, C. M., Holmes, J., Ladewig, D., & Ling, W. (2005). Buprenorphine induction and stabilisation in the treatment of opiate dependence. Heroin Addiction and Related Clinical Problems, 7(1), 7–18. doi:10.1016/j.jsat.2011.12.009.

Dutch, M. J. (2008). Nurofen Plus misuse: an emerging cause of perforated gastric ulcer. The Medical Journal of Australia, 188(1), 56–57.PubMed

Ernest, D., Chia, M., & Corallo, C. E. (2010). Profound hypokalaemia due to Nurofen Plus and Red Bull misuse. Critical care and resuscitation, 12(2), 109–110.PubMed

Evans, C., Chalmers-Watson, T. A., & Gearry, R. B. (2010). Medical Image. Combination NSAID-codeine preparations and gastrointestinal toxicity. New Zealand Medical Journal, 123(1324), 92–93.PubMed

Fareed, A., Vayalapalli, S., Casarella, J., & Drexler, K. (2012). Effect of Burprenorphine Dose on Treatment Outcome. Journal of Addictive Diseases, 31(1), 8–18. doi:10.1080/10550887.2011.642758.CrossRefPubMed

Fiellin, D. A., Schottenfeld, R. S., Cutter, C. J., Moore, B. A., Barry, D. T., & O’Connor, P. G. (2014). Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial. JAMA Internal Medicine, 174(12), 1947–1954. doi:10.1001/jamainternmed.2014.5302.CrossRefPubMed

Fine, P. G., Portenoy, R. K., & Ad Hoc Expert Panel on Evidence Review and Guidelines for Opioid Rotation (2009). Establishing ‘Best Practices’ for opioid rotation: conclusions of an expert panel. Journal of Pain and Symptom Management, 38(3), 418–425. doi:10.1016/j.jpainsymman.2009.06.002.CrossRefPubMedPubMedCentral

Frei, M. Y., Nielsen, S., Dobbin, M., & Tobin, C. L. (2010). Serious morbidity associated with misuse of over-the-counter codeine-ibuprofen analgesics: a series of 27 cases. The Medical Journal of Australia, 193(5), 294–296.PubMed

Gouveia, M., Sousa, R., Costa, J., & Borges, M. (2015). Economic evaluation of Suboxone® for substitution treatment of opioid drug dependence in Portugal. Heroin Addiction and Related Clinical Problems, 17(1), 43–50.

Gowing, L., Ali, R., & White, J. M. (2009). Buprenorphine for the management of opioid withdrawal. Cochrane Database of Systematic Reviews, 3, CD002025. doi:10.1002/14651858.CD002025.pub4.PubMed

Gowing, L., Farrell, M. F., Bornemann, R., Sullivan, L. E., & Ali, R. (2011). Oral substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database of Systematic Reviews, 8, CD004145. doi:10.1002/14651858.CD004145.pub4.PubMed

Gowing, L., Ali, R., Dunlop, A., Farrell, M., & Lintzeris, N. (2014). National Guidelines for Medication-Assisted Treatment of Opioid Dependence. Canberra: National Drug Strategy.

Handley, S. A., & Flanagan, R. J. (2014). Drugs and other chemicals involved in fatal poisoning in England and Wales during 2000–2011. Clinical Toxicology, 52(1), 1–12. doi:10.3109/15563650.2013.872791.CrossRefPubMed

Hard, B. (2014). Management of opioid painkiller dependence in primary care: ongoing recovery with buprenorphine/naloxone. British Medical Journal Case Reports. doi:10.1136/bcr-2014-207308.

Hser, Y., Saxon, A. J., Huang, D., Hasson, A., Thomas, C., Hillhouse, M., et al. (2014). Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial. Addiction, 109(1), 79–87. doi:10.1111/add.12333.

Kean, J (2015). Illicit and over-the-counter codeine dependence after acute back pain-successful treatment and ongoing recovery after buprenorphine/naloxone taper. Heroin Addiction And Related Clinical Problems.

Lambert, A. P., & Close, C. (2005). Life-threatening hypokalaemia from abuse of nurofen plus. Journal of the Royal Society of Medicine, 98(1), 21. doi:10.1258/jrsm.98.1.21.CrossRefPubMedPubMedCentral

Maas, J., Barton, G., Maskrey, V., Pinto, H., & Holland, R. (2013). Economic evaluation: a comparison of methadone versus buprenorphine for opiate substitution treatment. Drug and Alcohol Dependence, 133(2), 494–501. doi:10.1016/j.drugalcdep.2013.07.018.CrossRefPubMed

Marr, E., & Hill, D. (2015). Optimising service provision for prescribed opioid analgesic dependence. Heroin Addiction and Related Clinical Problems, 17(5), 13–18.

Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, Myers B, Ambekar A, & Strathdee SA; (2010). HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet, 375(9719):1014–1028. doi:10.1016/S0140-6736(10)60232–2.

Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews, 3, CD002209. doi:10.1002/14651858.CD002209.pub2.PubMed

Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014). Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews, 2, CD002207. doi:10.1002/14651858.CD002207.pub4.PubMed

McDonough, M. A. (2011). Misuse of codeine-containing combination analgesics. The Medical Journal of Australia, 194(9), 486.PubMed

Ministry of Health (2014). New Zealand practice guidelines for opioid SubstitutionTreatment. Wellington: Ministry of Health.

Mutlu, E., & Bilici, R. (2015). Outcomes of buprenorphine-naloxone maintenance therapy: one-year follow up study from Turkey. Heroin Addiction and Related Clinical Problems, 17(1), 79–90.

Myers, B., Siegfried, N., & Parry, C. D. (2003). Over-the-counter and prescription medicine misuse in cape town -findings from specialist treatment centres. South African Medical Journal, 93(5), 367–370.PubMed

National Institute for Health and Clinical Excellence (NICE) (2007). Drug misuse in over 16 s. Opioid detoxification. In Clinical guideline 52. London: NICE.

Ng, J. L., Morgan, D. J., Loh, N. K., Gan, S. K., ColemanPL, O. G. S., & Prentice, D. (2011). Life-threatening hypokalaemia associated with ibuprofen-induced renal tubular acidosis. The Medical Journal of Australia, 194(6), 313–316.PubMed

Nielsen, S., Cameron, & Pahoki, S. (2010). Over-the-counter codeine dependence. Melbourne, Australia: The Turning Point Alcohol and Drugs Centre.

Nielsen, S., Cameron, J., & Lee, N. (2011). Characteristics of a nontreatment-seeking sample of over-the-counter codeine users: implications for intervention and prevention. Journal of Opioid Management, 7(5), 363–370.PubMed

Nielsen, S., Hillhouse, M., Mooney, L., Fahey, J., & Ling, W. (2012). Comparing buprenorphine induction experience with heroin and prescription opioid users. Journal of Substance Abuse Treatment, 43(3), 285–290. doi:10.1016/j.jsat.2011.12.009.CrossRefPubMedPubMedCentral

Nielsen, S., Cameron, J., & Pahoki, S. (2013). Opportunities and challenges: over-the-counter codeine supply from the codeine consumer’s perspective. The International Journal of Pharmacy Practice, 21(3), 161–168. doi:10.1111/j.2042-7174.2012.00247.x.CrossRefPubMed

Nielsen, S., Roxburgh, A., Bruno, R., Lintzeris, N., Jefferson, A., & Degenhardt, L. (2015a). Changes in non-opioid substitution treatment episodes for pharmaceutical opioids and heroin from 2002 to 2011. Drug and Alcohol Dependence, 149, 212–219. doi:10.1016/j.drugalcdep.2015.02.004.CrossRefPubMed

Nielsen S, Bruno R, Murnion B, Dunlop A, Degenhardt L, Demirkol A, Muhleisen P, Lintzeris N. (2015b). Treating codeine dependence with buprenorphine: Dose requirements and induction outcomes from a retrospective case series in New South Wales, Australia. Drug and Alcohol Review. Early Online. doi:10.1111/dar.12315.

Nielsen, S., Murnion, B., Dunlop, A., Degenhardt, L., Demirkol, A., Muhleisen, P., et al. (2015c). Comparing treatment-seeking codeine users and strong opioid users: findings from a novel case series. Drug and Alcohol Review, 34(3), 304–311. doi:10.1111/dar.12315.

Pilgrim, J. L., Dobbin, M., & Drummer, O. H. (2013). Fatal misuse of codeine-ibuprofen analgesics in Victoria, Australia. The Medical Journal of Australia, 199(5), 329–331. doi:10.5694/mja12.11843.CrossRefPubMed

Reed K, Bond A, Witton J, Cornish R, Hickman M, & Strang J. (2011). The changing use of prescribed benzodiazepines and z-drugs and of over-the-counter codeine-containing products in England: a structured review of published English and international evidence and available data to inform consideration of the extent of dependence and harm. London. National Addiction Centre.

Riksheim, M., Gossop, M., & Clausen, T. (2014). From methadone to buprenorphine: changes during a 10 year period within a national opioid maintenance treatment programme. Journal of Substance Abuse Treatment, 46(3), 291–294. doi:10.1016/j.jsat.2013.10.006.CrossRefPubMed

Sigmon, S. C., Dunn, K. E., Badger, G. J., Heil, S. H., & Higgins, S. T. (2009). Brief buprenorphine detoxification for the treatment of prescription opioid dependence: a pilot study. Addictive Behaviours, 34(3), 304–311. doi:10.1016/j.addbeh.2008.11.017.CrossRef

Soyka, M. (2015). New developments in the management of opioid dependence: focus on sublingual buprenorphine-naloxone. Substance Abuse and Rehabilitation, 6, 1–14. doi:10.2147/SAR.S45585.CrossRefPubMedPubMedCentral

Stannard, C. (2013). Opioids in the UK: what’s the problem? BMJ, 347, f5108. doi:10.1136/bmj.f5108.CrossRefPubMed

Strike C, Millson M, Hopkins S, Smith C (2013). What is low threshold methadone maintenance treatment? International Journal of Drug Policy 24(6), 51–56.

The Royal College of General Practitioners (2014). Prescription and over-the-counter medicines misuse and dependence. 1--4. http://www.rcgp.org.uk/learning.

Van Hout, M. C. (2015). Nod and wave: an internet study of the codeine intoxication phenomenon. International Journal of Drug Policy, 26(1), 67–77. doi:10.1016/j.drugpo.2014.06.016.CrossRefPubMed

Van Hout, M. C., & Norman, I. (2015). Misuse of non-prescription codeine containing products: recommendations for detection and reduction of risk in community pharmacies. In International journal of drug policy. Early: Online. doi:10.1016/j.drugpo.2015.09.007.

Van Hout MC, Bergin M, Foley M, Rich E, Rapca AI, Harris R, & Norman I. (2014). A Scoping Review of Codeine Use, Misuse and Dependence, final report. CODEMISUSED Project European Commission 7th Framework Programme, EU. Brussels.

Van Hout MC, Horan A, Santlal K, Rich E, Bergin M. (2015a). ‘Codeine is my Companion’: Misuse and dependence on codeine containing medicines in Ireland. Irish Journal of Psychological Medicine. Early Online.

Van Hout MC, Rich E, Dada S, Bergin M. (2015b). Codeine is my Helper: A qualitative study of pharmacy access and codeine misuse in South Africa. Qualitative Health Research. Early Online. doi:10.1177/1049732315613764

Weiss, R. D., Potter, J. S., Fiellin, D., Byrne, M., Connery, H. S., Dickinson, W., et al. (2011). Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for presciption opioid dependence: a 2-phase randomized controlled trial. Archives of General Psychiatry, 68(12), 1238–1246. doi:10.1001/archgenpsychiatry.2011.121.

Wright, N. M. J., Sheard, L., Tompkins, C. N. E., Adams, C. E., Allgar, V. L., & Oldham, N. S. (2007). Buprenorphine versus dihydrocodeine for opiate detoxification in primary care: a randomised controlled trial. BMC Family Practice, 8, 3. doi:10.1186/1471-2296-8-3.g.CrossRefPubMedPubMedCentral

Titel: Dependence on Over the Counter (OTC) Codeine Containing Analgesics: Treatment and Recovery with Buprenorphine Naloxone
verfasst von: Marie Claire Van Hout
Ide Delargy
Gerry Ryan
Siobhan Flanagan
Hugh Gallagher
Publikationsdatum: 14.12.2015
Verlag: Springer US
Erschienen in: International Journal of Mental Health and Addiction / Ausgabe 5/2016
Print ISSN: 1557-1874
Elektronische ISSN: 1557-1882
DOI: https://doi.org/10.1007/s11469-015-9618-2

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Dependence on Over the Counter (OTC) Codeine Containing Analgesics: Treatment and Recovery with Buprenorphine Naloxone

Abstract

Neu im Fachgebiet Psychiatrie

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

ADHS-Medikation erhöht das kardiovaskuläre Risiko

Klinikreform soll zehntausende Menschenleben retten

Typ-2-Diabetes und Depression folgen oft aufeinander

Update Psychiatrie

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2016

The Mechanisms of Mindfulness in the Treatment of Mental Illness and Addiction

Critical Review of Dual Diagnosis Training for Mental Health Professionals

A Mindfulness-Based Group Intervention for Enhancing Self-Regulation of Emotion in Late Childhood and Adolescence: A Pilot Study

Pain and Suicidal Behavior in Primary Care Patients: Mediating Role of Interpersonal Needs

Erratum to: The Impact of a Motor Affordance Intervention on Motor and Cognitive Development of Young Children

Clinical Indicators of Successful Substance Use Treatment among Adults in the Criminal Justice System

Neu im Fachgebiet Psychiatrie

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

ADHS-Medikation erhöht das kardiovaskuläre Risiko

Klinikreform soll zehntausende Menschenleben retten

Typ-2-Diabetes und Depression folgen oft aufeinander

Update Psychiatrie